Table 2.
Patient demographics | Total cohort (N = 165) | IC-MPGN (n = 42) | C3G (n = 43) | P value (IC-MPGN vs. C3G) |
---|---|---|---|---|
Age at diagnosis (yr) | 9.3 (8.7–10.0) | 9.6 (8.7 – 10.5) | 10.1 (9.0–11.3) | NS (0.5647) |
Age at last follow-up (yr) | 13.4 (12.6–14.0) | 13.6 (12.5–14.7) | 14.1 (13.0–15.2) | NS (0.5104) |
Follow-up time (yr) | 4.0 (3.4–4.6) | 4.0 (3.1–5.0) | 4.0 (3.1–4.8) | NS (0.9072) |
Sex | ||||
Male | 78 | 21 | 15 | NS (0.1910) |
Female | 87 | 21 | 28 | |
Race | ||||
White | 109 | 27 | 22 | NS (0.2744) |
Asian | 13 | 5 | 4 | NS (0.7334) |
American Indian | 2 | 1 | 0 | NS (0.4941) |
Black | 13 | 3 | 2 | NS (0.6761) |
Mixed race | 7 | 4 | 2 | NS (0.4331) |
Native Hawaiian/Pacific Islander | 2 | 0 | 0 | NS (>0.9999) |
Unknown | 19 | 2 | 13 | 0.0034a |
Weight at diagnosis (kg) | 38.6 (34.6–42.6) | 36.4 (32.3–40.7) | 42.6 (34.4–50.8) | NS (0.1883) |
Weight at last follow-up (kg) | 49.5 (45.6–53.4) | 51.4 (45.2–57.6) | 52.2 (46.8–57.7) | NS (0.8610) |
Height at diagnosis (cm) | 133.0 (127.9–138.0) | 138.1 (132.3–144.0) | 135.9 (127.1–144.7) | NS (0.6691) |
Height at last follow-up (cm) | 149.0 (145.0–153.0) | 154.0 (148.6–159.4) | 155.5 (150.2–160.8) | NS (0.6337) |
C3G, C3 glomerulopathy; IC-MPGN, immune-complex membranoproliferative glomerulonephritis; NS, not significant.
Numeric data are shown as the mean with 95% confidence interval.
Statistically significant.